A systems genomics approach to uncover patient-specific pathogenic pathways and proteins in ulcerative colitis
Johanne Brooks-Warburton(University of Hertfordshire), Tamás Korcsmáros(Eötvös Loránd University), Dávid Fazekas(Eötvös Loránd University), Balázs Bohár(Eötvös Loránd University), Séverine Vermeire(KU Leuven), Andreas Bender(Munich School of Philosophy), Bram Verstockt(Universitair Ziekenhuis Leuven), Matthew Madgwick(Quadram Institute), Lindsay J. Hall(University of Birmingham), Alastair J.M. Watson(University of Liverpool), Simon R. Carding(University of East Anglia), Dezső Módos(University of Cambridge), Miles Parkes(Cambridge University Hospitals NHS Foundation Trust), Orsolya Kapuy(Semmelweis University), Azedine Zoufir(University of Cambridge), Padhmanand Sudhakar(KU Leuven), Mark Tremelling(Norfolk and Norwich University Hospital), John P. Thomas(Norwich Research Park), Máté Szalay-Bekő(Norwich Research Park)
Cited by 28
Related Papers
Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations
|Nature Genetics|2015|2.8k
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease
|Nature Genetics|2008|2.6k
ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications
|Journal of Crohn s and Colitis|2018|1.8k
Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease
|New England Journal of Medicine|2016|1.8k